GENERAL ASPECTS AND CLINICAL MANIFESTATIONS IN YOUNG PATIENTS WITH PRIMARY MYELOFIBROSIS.
PDF

Як цитувати

Sghibneva-Bobeico, N., Musteata, V., & Munteanu, V. (2021). GENERAL ASPECTS AND CLINICAL MANIFESTATIONS IN YOUNG PATIENTS WITH PRIMARY MYELOFIBROSIS. InterConf, (76). вилучено із https://ojs.ukrlogos.in.ua/index.php/interconf/article/view/14752
PDF

Посилання

Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet. 2005;365:1054-1061.

Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood. 2009;114:937-951.

Corcimaru I., Hematologie 2007; 190

Primary myelofibrosis: own experience and news from diagnostic and treatment K.M. Abdulkadyrov, V.A. Shuvaev, I.S. Martynkevich Russian Research Institute of Hematology and Transfusiology, Federal Medical and Biological Agency; 16, 2 nd Sovetskaya St., St. Petersburg, 191024, Russia, p 26.

Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management. Ayalew Tefferi 1

Creative Commons License

Ця робота ліцензується відповідно до Creative Commons Attribution 4.0 International License.

Завантаження

Дані завантаження ще не доступні.

| Переглядів: 14 | Завантажень: 28 |